Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Precision Biosciences (DTIL) Accumulated Depreciation & Amortization (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Accumulated Depreciation & Amortization for 8 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization fell 56.82% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 56.82% year-over-year, with the annual reading at $1.5 million for FY2025, 56.82% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $1.5 million at Precision Biosciences, down from $3.4 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $25.5 million in Q4 2023, with the low at $1.5 million in Q4 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $15.2 million, with a median of $21.9 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization increased 25.35% in 2021, then plummeted 86.66% in 2024.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $23.9 million in 2021, then decreased by 8.55% to $21.9 million in 2022, then grew by 16.55% to $25.5 million in 2023, then tumbled by 86.66% to $3.4 million in 2024, then plummeted by 56.82% to $1.5 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $1.5 million, $3.4 million, and $25.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.